VCM
EHC icon

Versant Capital Management’s Encompass Health EHC Stock Holding History

Versant Capital Management’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.8K Buy
720
+129
+22% +$13.4K 0.01% 1105
2026
Q1 		$57.2K Sell
591
-1,149
-66% -$118K 0.01% 1149
2025
Q4 		$185K Sell
1,740
-26
-1% -$3.01K 0.02% 521
2025
Q3 		$224K Buy
1,766
+29
+2% +$3.45K 0.03% 429
2025
Q2 		$213K Hold
1,737
– – 0.03% 425
2025
Q1 		$176K Buy
1,737
+1,383
+391% +$135K 0.03% 458
2024
Q4 		$32.7K Buy
354
+98
+38% +$9.62K 0.01% 762
2024
Q3 		$24.7K Buy
256
+4
+2% +$359 0.01% 733
2024
Q2 		$21.6K Buy
252
+229
+996% +$19.2K 0.01% 684
2024
Q1 		$1.9K Hold
23
– – ﹤0.01% 1369
2023
Q4 		$1.53K Hold
23
– – ﹤0.01% 1383
2023
Q3 		$1.54K Hold
23
– – ﹤0.01% 1393
2023
Q2 		$1.56K Sell
23
-26
-53% -$1.63K ﹤0.01% 1460
2023
Q1 		$2.65K Buy
49
+43
+717% +$2.5K ﹤0.01% 1189
2022
Q4 		$359 Hold
6
– – ﹤0.01% 1485
2022
Q3 		$0 Sell
6
-2
-25% -$100 ﹤0.01% 1478
2022
Q2 		$0 Hold
8
– – ﹤0.01% 1486
2022
Q1 		$0 Hold
8
– – ﹤0.01% 1499
2021
Q4 		$0 Sell
8
-7
-47% -$361 ﹤0.01% 1474
2021
Q3 		$1K Hold
15
– – ﹤0.01% 1253
2021
Q2 		$1K Sell
15
-5
-25% -$333 ﹤0.01% 1262
2021
Q1 		$1K Sell
20
-39
-66% -$2.54K ﹤0.01% 1343
2020
Q4 		$3K Hold
59
– – ﹤0.01% 1039
2020
Q3 		$3K Hold
59
– – ﹤0.01% 971
2020
Q2 		$2K Hold
59
– – ﹤0.01% 1048
2020
Q1 		$3K Hold
59
– – ﹤0.01% 907
2019
Q4 		$3K Sell
59
-23
-28% -$1.25K ﹤0.01% 1056
2019
Q3 		$4K Sell
82
-3
-4% -$151 ﹤0.01% 1005
2019
Q2 		$4K Hold
85
– – ﹤0.01% 1013
2019
Q1 		$3K Buy
85
+3
+4% +$152 ﹤0.01% 1244
2018
Q4 		$4K Hold
82
– – ﹤0.01% 1084
2018
Q3 		$5K Sell
82
-7
-8% -$426 ﹤0.01% 1081
2018
Q2 		$4K Hold
89
– – ﹤0.01% 1132
2018
Q1 		$4K Hold
89
– – ﹤0.01% 1119
2017
Q4 		$3K Sell
89
-19
-18% -$723 ﹤0.01% 1238
2017
Q3 		$3K Buy
108
+24
+29% +$855 ﹤0.01% 1156
2017
Q2 		$3K Hold
84
– – ﹤0.01% 1158
2017
Q1 		$2K Sell
84
-33
-28% -$1.08K ﹤0.01% 1220
2016
Q4 		$3K Buy
117
+54
+86% +$1.75K ﹤0.01% 1117
2016
Q3 		$2K Hold
63
– – ﹤0.01% 1171
2016
Q2 		$1K Sell
63
-7
-10% -$219 ﹤0.01% 1235
2016
Q1 		$2K Buy
70
+57
+438% +$1.57K ﹤0.01% 1120
2015
Q4 		$0 Buy
+13
New +$370 ﹤0.01% 1361

Other funds holding EHC

RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
LDB
Lee, Danner & Bass Nashville, Tennessee $1.73B AUM 36.69% 1-Year Est. Return
BCA
Bernzott Capital Advisors Camarillo, California $250M AUM 26.89% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
BG
BDF Gestion Paris, France $747M AUM 47.35% 1-Year Est. Return
SCM
Seascape Capital Management Portsmouth, New Hampshire $417M AUM 41.98% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Versant Capital Management's EHC Position: Q2 2026 in Review

Versant Capital Management increased its Encompass Health (EHC) stake by 22% in Q2 2026, buying an estimated $13.4K and bringing the position to 720 shares worth $72.8K. The position accounts for 0.01% of the portfolio, ranked #1105.

Versant Capital Management first reported a position in EHC in Q4 2015 and has held it in 43 quarters since. The position peaked at $224K in Q3 2025. 79 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Versant Capital Management held 720 shares of Encompass Health worth $72.8K as of Q2 2026.
  • Versant Capital Management bought 129 Encompass Health shares in Q2 2026, an estimated $13.4K.
  • Encompass Health made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #1105 holding.
  • Versant Capital Management first reported a position in Encompass Health in Q4 2015 and has held it in 43 quarters since.
  • Versant Capital Management's Encompass Health position peaked at $224K in Q3 2025.
  • 79 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.